Neurogene (NGNE) Return on Sales (2023 - 2025)
Historic Return on Sales for Neurogene (NGNE) over the last 6 years, with Q3 2025 value amounting to 1084.71%.
- Neurogene's Return on Sales rose 13014900.0% to 1084.71% in Q3 2025 from the same period last year, while for Sep 2025 it was 1084.71%, marking a year-over-year increase of 13014900.0%. This contributed to the annual value of 81.84% for FY2024, which is N/A changed from last year.
- Latest data reveals that Neurogene reported Return on Sales of 1084.71% as of Q3 2025, which was up 13014900.0% from 1075.41% recorded in Q2 2025.
- Neurogene's 5-year Return on Sales high stood at 17553.33% for Q4 2023, and its period low was 234.38% during Q4 2024.
- For the 3-year period, Neurogene's Return on Sales averaged around 4052.61%, with its median value being 1075.41% (2025).
- As far as peak fluctuations go, Neurogene's Return on Sales tumbled by -177877200bps in 2024, and later skyrocketed by 13014900bps in 2025.
- Quarter analysis of 3 years shows Neurogene's Return on Sales stood at 17553.33% in 2023, then tumbled by -101bps to 234.38% in 2024, then soared by 563bps to 1084.71% in 2025.
- Its last three reported values are 1084.71% in Q3 2025, 1075.41% for Q2 2025, and 284.91% during Q1 2025.